Vijaya Diagnostic Centre has announced its Q2 FY26 results, showcasing a 10.2% year-over-year increase in revenue, reaching INR 2,016 Mn. EBITDA stood at INR 818 Mn with a margin of 40.6%, while PAT reached INR 433 Mn with a margin of 21.5%. The company continues its expansion strategy, including hub center inaugurations and acquisitions.
Financial Performance
Vijaya Diagnostic Centre reported steady revenue growth for Q2 FY26, achieving a 10.2% year-over-year increase, driven by volume growth. Key financial highlights include:
- Revenue from Operations: INR 2,016 Mn
- EBITDA: INR 818 Mn with a margin of 40.6%
- PAT: INR 433 Mn with a margin of 21.5%
H1 FY26 Overview
The company’s performance for the first half of FY26 also demonstrated strong growth:
- Revenue from Operations: INR 3,896 Mn
- EBITDA: INR 1,554 Mn with a margin of 39.9%
- PAT: INR 819 Mn with a margin of 21.0%
The revenue split from B2C is 92%.
Strategic Developments
Vijaya Diagnostic Centre has continued its expansion, marked by several key developments:
- Inaugurated a state-of-the-art hub in Kasba, Kolkata during Q2 FY26.
- Inaugurated a state-of-the-art hub in Nandyal, AP in October 2025.
- Inaugurated a state-of-the-art hub in Khammam, Telangana in October 2025.
- Launched a Spoke in Alwal, Hyderabad in September 2025.
Merger and Expansion
The NCLT order for the merger of Medinova Diagnostic Services Limited with Vijaya was received in October 2025, effective from April 1, 2024.
The company finalized the lease for a flagship center at Bannerghatta, Bengaluru, which will feature advanced equipment and an automated lab.
Future Expansion Plans
Future expansion plans include:
- Two additional hubs are on track to be commissioned in West Bengal by the end of FY26.
- Planning to add a hub in Bengaluru during H1 FY27.
Source: BSE